Advent International to acquire stake in Felix Pharmaceuticals

Advent International is set to invest $175 million in Felix Pharmaceuticals, acquiring a significant minority stake. Felix Pharma, a Dublin-based company, specializes in generic animal pharmaceuticals, particularly for companion animals. With 14 USFDA-approved products and a robust pipeline, Felix aims to expand its global presence with Advent's support and expertise.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/U54rIpD
via IFTTT